Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy.

Exclusion Criteria

• •1. History of intolerance to eHF formula
• •2. Any chronic medical diseases (except atopic eczema), chromosomal or major congenital anomalies (based on medical history and/or commonly performed diagnostic criteria)
• •3. Major gastrointestinal disease / abnormalities (other than CMPA)
• •4. Known or suspected lactose intolerance or malabsorption
• •5. Known or suspected soy allergy
• •6. Glucose-galactose malabsorption
• •7. Rice protein allergy or intolerance (e.g., rice protein-induced enterocolitis syndrome).
• •8. Immunodeficiency
• •9. Persistent wheeze or chronic respiratory disease
• •10. Severe uncontrolled eczema
• •11. History of severe anaphylactic reaction (e.g., requiring ≥ 2 doses of epinephrine) to cow's milk or breast milk at any time prior to enrollment
• •12. Weight-for-age value \< -2 or \> 2 standard deviations from the WHO Child Growth Standards median at enrollment
• •13. Height-for-age \< -2 or \> 2 standard deviations from the WHO Child Growth Standards median at enrollment
• •14. Infant's parent has other medical or psychiatric condition that, in the judgement of the investigator, would make the infant inappropriate for entry into the study
• •15. Currently participating or having participated in another interventional clinical study within 4 weeks prior to enrollment